BLCO vs. DHR: Which Stock Should Value Investors Buy Now?

Core Viewpoint - Investors in the Medical Services sector should consider Bausch + Lomb (BLCO) and Danaher (DHR) for potential value opportunities, with BLCO currently appearing to offer better value for investors [1]. Valuation Metrics - BLCO has a forward P/E ratio of 26.75, while DHR has a forward P/E of 27.39, indicating that BLCO may be more attractively priced [5]. - The PEG ratio for BLCO is 1.49, compared to DHR's PEG ratio of 3.03, suggesting that BLCO has a better earnings growth outlook relative to its price [5]. - BLCO's P/B ratio is 0.8, significantly lower than DHR's P/B of 2.91, indicating that BLCO is trading at a lower market value compared to its book value [6]. Zacks Rank and Style Scores - BLCO has a Zacks Rank of 2 (Buy), while DHR has a Zacks Rank of 3 (Hold), reflecting a more favorable earnings outlook for BLCO [3]. - BLCO has earned a Value grade of B, whereas DHR has a Value grade of C, further supporting the notion that BLCO is the better option for value investors [6].